World's Best Scientists 2026 revealed!
Francesco Di Raimondo

Francesco Di Raimondo

D-Index & Metrics

Medicine

D-Index
81
Citations
27437
World Ranking
16512
National Ranking
656

Overview

Francesco Di Raimondo is affiliated with the University of Catania in Italy and has a substantial body of work in the field of medicine, particularly focusing on hematology and oncology. Their research spans several subfields including genetics, molecular biology, and pathology.

The scientist's recent papers demonstrate active engagement with current issues in hematological malignancies and treatment resistance. Notable publications include:

  • "Bosutinib for pretreated patients with chronic phase chronic myeloid leukemia: primary results of the phase 4 BYOND study" (2020, Leukemia)
  • "Philadelphia-like acute lymphoblastic leukemia is associated with minimal residual disease persistence and poor outcome. First report of the minimal residual disease-oriented GIMEMA LAL1913" (2020, Haematologica)
  • "Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells" (2020, Biomolecules)
  • "A multicenter total therapy strategy for de novo adult Philadelphia chromosome positive acute lymphoblastic leukemia patients: final results of the GIMEMA LAL1509 protocol" (2021, Haematologica)
  • "CD49d promotes disease progression in chronic lymphocytic leukemia: new insights from CD49d bimodal expression" (2020, Blood)

Frequent co-authors in their research include:

  • Alessandra Romano
  • Concetta Conticello
  • Giuseppe A. Palumbo
  • Andrea Duminuco
  • Massimo Gentile

Francesco Di Raimondo has published extensively in respected venues within the hematology and oncology communities. Common publication venues are:

  • Blood
  • HemaSphere
  • Haematologica
  • Frontiers in Oncology
  • Cancers

Their research focuses on the following main topics of interest:

  • Multiple Myeloma Research and Treatments
  • Chronic Lymphocytic Leukemia Research
  • Acute Myeloid Leukemia Research
  • Lymphoma Diagnosis and Treatment
  • Protein Degradation and Inhibitors
  • Chronic Myeloid Leukemia Treatments
  • Myeloproliferative Neoplasms: Diagnosis and Treatment

Best Publications

  • BRAF mutations in hairy-cell leukemia

    Enrico Tiacci;Vladimir Trifonov;Gianluca Schiavoni;Antony Holmes

  • Bortezomib with thalidomide plus dexamethasone compared with thalidomide plus dexamethasone as induction therapy before, and consolidation therapy after, double autologous stem-cell transplantation in newly diagnosed multiple myeloma: a randomised phase 3 study

    Michele Cavo;Paola Tacchetti;Francesca Patriarca;Maria Teresa Petrucci

  • Early Interim 2-[18F]Fluoro-2-Deoxy-D-Glucose Positron Emission Tomography Is Prognostically Superior to International Prognostic Score in Advanced-Stage Hodgkin's Lymphoma: A Report From a Joint Italian-Danish Study

    Andrea Gallamini;Martin Hutchings;Luigi Rigacci;Lena Specht

  • Autologous transplantation and maintenance therapy in multiple myeloma

    Antonio Palumbo;Federica Cavallo;Francesco Di Raimondo

  • Follicular Lymphoma International Prognostic Index 2: A New Prognostic Index for Follicular Lymphoma Developed by the International Follicular Lymphoma Prognostic Factor Project

    Massimo Federico;Monica Bellei;Luigi Marcheselli;Stefano Luminari

  • Brentuximab vedotin with chemotherapy for CD30-positive peripheral T-cell lymphoma (ECHELON-2): a global, double-blind, randomised, phase 3 trial

    Steven Horwitz;Owen A O'Connor;Barbara Pro;Tim Illidge

  • Treatment of Older Patients with Mantle-Cell Lymphoma

    H. C. Kluin-Nelemans;Eva Hoster;Olivier Hermine;J. Walewski

  • Imatinib plus steroids induces complete remissions and prolonged survival in elderly Philadelphia chromosome-positive patients with acute lymphoblastic leukemia without additional chemotherapy: results of the Gruppo Italiano Malattie Ematologiche dell'Adulto (GIMEMA) LAL0201-B protocol

    Marco Vignetti;Paola Fazi;Giuseppe Cimino;Giovanni Martinelli

  • Prospective, Randomized Study of Single Compared With Double Autologous Stem-Cell Transplantation for Multiple Myeloma: Bologna 96 Clinical Study

    Michele Cavo;Patrizia Tosi;Elena Zamagni;Claudia Cellini

  • Treatment of adult acute lymphoblastic leukemia (ALL): long-term follow-up of the GIMEMA ALL 0288 randomized study.

    Luciana Annino;Maria Luce Vegna;Andrea Camera;Giorgina Specchia

  • Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group

    Francesco Lo-Coco;Giuseppe Avvisati;Marco Vignetti;Massimo Breccia

  • Melphalan, Prednisone, and Lenalidomide Treatment for Newly Diagnosed Myeloma: A Report From the GIMEMA—Italian Multiple Myeloma Network

    Antonio Palumbo;Patrizia Falco;Paolo Corradini;Antonietta Falcone

  • Aspirin or enoxaparin thromboprophylaxis for patients with newly diagnosed multiple myeloma treated with lenalidomide

    Alessandra Larocca;Federica Cavallo;Sara Bringhen;Francesco Di Raimondo

  • Prospective, multicenter randomized GITMO/IIL trial comparing intensive (R-HDS) versus conventional (CHOP-R) chemoimmunotherapy in high-risk follicular lymphoma at diagnosis: the superior disease control of R-HDS does not translate into an overall survival advantage

    Marco Ladetto;Federica De Marco;Fabio Benedetti;Umberto Vitolo

  • Health-related quality of life in chronic myeloid leukemia patients receiving long-term therapy with imatinib compared with the general population

    Fabio Efficace;Michele Baccarani;Massimo Breccia;Giuliana Alimena

  • Whole-exome sequencing identifies somatic mutations of BCOR in acute myeloid leukemia with normal karyotype

    Vera Grossmann;Enrico Tiacci;Antony B. Holmes;Alexander Kohlmann

  • Bortezomib-Melphalan-Prednisone-Thalidomide Followed by Maintenance With Bortezomib-Thalidomide Compared With Bortezomib-Melphalan-Prednisone for Initial Treatment of Multiple Myeloma: Updated Follow-Up and Improved Survival

    Antonio Palumbo;Sara Bringhen;Alessandra Larocca;Davide Rossi

  • A comprehensive genetic classification of adult acute lymphoblastic leukemia (ALL): analysis of the GIMEMA 0496 protocol.

    Marco Mancini;Daniela Scappaticci;Giuseppe Cimino;Mauro Nanni

  • The EUTOS population-based registry: incidence and clinical characteristics of 2904 CML patients in 20 European Countries

    V. S. Hoffmann;M. Baccarani;J. Hasford;D. Lindoerfer

  • R-CVP Versus R-CHOP Versus R-FM for the Initial Treatment of Patients With Advanced-Stage Follicular Lymphoma: Results of the FOLL05 Trial Conducted by the Fondazione Italiana Linfomi

    Massimo Federico;Stefano Luminari;Alessandra Dondi;Alessandra Tucci

Frequent Co-Authors

Pellegrino Musto
Pellegrino Musto University of Bari Aldo Moro
Maria Teresa Petrucci
Maria Teresa Petrucci Sapienza University of Rome
Mario Boccadoro
Mario Boccadoro University of Turin
Michele Cavo
Michele Cavo University of Bologna
Antonio Palumbo
Antonio Palumbo University of Turin
Gianluca Gaidano
Gianluca Gaidano University of Eastern Piedmont Amadeo Avogadro
Robin Foà
Robin Foà Sapienza University of Rome
Antonino Neri
Antonino Neri University of Milan
Giorgina Specchia
Giorgina Specchia University of Bari Aldo Moro
Davide Rossi
Davide Rossi European Society for Medical Oncology

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in medicine doesn’t always follow a single path. Today, there are flexible and fully online options for students eager to break into the healthcare field or advance their careers. For those interested in wellness and disease prevention, pursuing nutrition degrees online can open doors in clinical nutrition, public health, and food science.

If your goals include healthcare leadership, consider enrolling in one of the best online mha programs to develop management and policy skills tailored for hospitals and healthcare systems. Registered nurses seeking higher qualifications may benefit from earning their bachelor’s through an rn to bsn with no clinicals program, eliminating the need for additional on-site practicum.

Lastly, advanced practice nurses can accelerate their careers with the fastest msn to dnp program, moving into leadership, research, or advanced clinical practice roles. These related online programs broaden opportunities and offer new ways to impact patient care beyond the traditional path to a medical doctorate.

Best Scientists Citing Francesco Di Raimondo

Trending Scientists